C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation (scientific article published on 15 December 2014)

Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 mediates C-reactive protein-evoked endothelial vasodilator dysfunction in coronary arterioles

Q24338726

C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells.

Q54634787

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

Q54750642

Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques

Q57132361

The kidney as a second site of human C-reactive protein formation in vivo

Q73022229

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

Q73083027

Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue

Q73500521

C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes

Q77522454

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

Q77531127

[C-reactive protein: cardiovascular issues of an acute-phase protein]

Q80328869

Leptin induces C-reactive protein expression in vascular endothelial cells

Q80576671

Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation

Q81227859

Evidence that complement protein C1q interacts with C-reactive protein through its globular head region

Q82625735

Modified C-reactive protein interacts with platelet glycoprotein Ibα

Q84165501

Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study

Q84218408

Platelets affect the structure and function of C-reactive protein

Q84242242

Early verification of myocardial ischemia with a novel biomarker of acute tissue damage: C-reactive protein fractional forms

Q84463393

An about-face for C-reactive protein?

Q84707321

Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions

Q84819044

Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective

Q24594814

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?

Q24602803

C-reactive protein: a critical update

Q24672855

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

Q24673242

Inflammation and metabolic dysfunction: links to cardiovascular diseases

Q26851186

Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases

Q27008359

The physiological structure of human C-reactive protein and its complex with phosphocholine

Q27618638

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Q27861020

Nitric oxide synthases: structure, function and inhibition

Q28207668

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Q28235865

Fcgamma receptors: old friends and new family members

Q28291895

Adipokines in inflammation and metabolic disease

Q29620456

Topology and structure of the C1q-binding site on C-reactive protein

Q32133439

Fcgamma receptors: structure, function and role as genetic risk factors in SLE

Q33697484

Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome

Q33788524

The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice

Q33821359

Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.

Q34021492

Chronic inflammation in obesity and the metabolic syndrome

Q34035348

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

Q34191416

Monomeric C-reactive protein alters fibrin clot properties on endothelial cells

Q34220088

Identification of acidic pH-dependent ligands of pentameric C-reactive protein

Q34285524

C-reactive Protein

Q34344434

No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice

Q34675880

Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

Q34683473

CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme

Q34769808

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease

Q34907912

Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor

Q34947183

Atherosclerosis-Related Functions of C-Reactive Protein

Q35073552

The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action

Q35138588

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells

Q35145964

Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis

Q35728529

Generation of C-reactive protein and complement components in atherosclerotic plaques

Q35746446

Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).

Q51717888

Studies on the interactions between C-reactive protein and complement proteins.

Q52576446

C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.

Q54414303

Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow.

Q54566349

The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.

Q54589744

Monomeric C-reactive protein and inflammatory injury in myocardial infarction

Q42325772

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

Q42450459

Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance

Q43060919

C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase

Q43062276

The homocysteine paradox.

Q43236874

Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H.

Q43292217

C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.

Q43739933

C-reactive protein isoforms differ in their effects on thrombus growth

Q43887011

Lectin-like oxidized low-density lipoprotein receptor-1 plays an important role in vascular inflammation in current smokers

Q43975643

Vascular smooth muscle cell activation by C-reactive protein

Q44385110

Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein

Q44477046

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

Q45096516

Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells

Q46243550

C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells

Q46588117

Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease

Q46681831

Production of modified C-reactive protein in U937-derived macrophages

Q46772279

FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase

Q46790570

Mechanical strain induces expression of C-reactive protein in human blood vessels

Q47929761

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

Q36346658

Complement activity and pharmacological inhibition in cardiovascular disease

Q36405114

C-reactive protein, inflammatory conditions, and cardiovascular disease risk

Q36408376

C-reactive protein in atherosclerosis: A causal factor?

Q36453512

Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats

Q36558323

Adipose tissue-derived factors: impact on health and disease

Q36631232

Should C-reactive protein be a target of therapy?

Q36783729

Impact of C-reactive protein on disease risk and its relation to dietary factors.

Q36909201

Adipokines mediate inflammation and insulin resistance

Q36920864

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

Q37045449

The evolving role of C-reactive protein in atherothrombosis

Q37144130

Controlling the cardiovascular disease epidemic

Q37163443

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Q37323477

Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss

Q37331151

Regulation of cell function by isoforms of C-reactive protein: a comparative analysis.

Q37393773

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling

Q37408109

The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.

Q37416223

C-reactive protein: clinical and epidemiological perspectives.

Q37599325

A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions

Q37621931

C-reactive protein: how conformational changes influence inflammatory properties

Q37627097

Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk

Q37728665

Relation of C-reactive protein to abdominal adiposity

Q37770665

Dendritic cells and regulatory T cells in atherosclerosis

Q38023274

C-reactive protein and atherothrombosis: Cause or effect?

Q38069724

C-reactive protein and lung diseases

Q38213960

Recognition functions of pentameric C-reactive protein in cardiovascular disease

Q38221846

C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.

Q38333783

Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation

Q39494024

Expression of C-reactive protein in the human respiratory tract

Q39518908

C-reactive protein: binding to lipids and lipoproteins

Q39843358

CRP is a novel ligand for the oxidized LDL receptor LOX-1.

Q39878373

Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells

Q39904920

Phylogenetic aspects of C-reactive protein and related proteins

Q40333638

Linking inflammation and thrombosis: Role of C-reactive protein

Q41332165

Interaction of C-reactive protein with artificial phosphatidylcholine bilayers

Q41752082

Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop

Q41975793

Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations

Q42021566

C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype

Q42042963

P275

Creative Commons Attribution 3.0 Unported

copyrighted

page(s)

653045

P577

publication date

2014-12-15

P1433

published in

International scholarly research notices

Q27726015

P1476

title

C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation

P478

volume

2014

Reverse relations

cites work (P2860)

Q89898692	Association between C reactive protein and all-cause mortality in the ELSA-Brasil cohort
Q64110033	Characterization of a subgroup of non-type 2 asthma with cow's milk hypersensitivity in young subjects
Q52677743	Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.
Q92405017	Functionality of C-Reactive Protein for Atheroprotection
Q64100462	Structure-Function Relationships of C-Reactive Protein in Bacterial Infection
Q54946388	The Effect of Pycnogenol Supplementation on Plasma C-Reactive Protein Concentration: a Systematic Review and Meta-Analysis.